Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

Emtherapro

Emtherapro is a biotech company that offers precision medicine enablement solutions for neurogenetic disorders.
2021
Decatur, Georgia, United States

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

3.M

Last Funding Amount

3.M

Last Funding Date

07-09-2023

Startup Stage

Seed

Something missing or incorrect on this page? Help us enrich this information